April Yunkyoung Lee

April Yunkyoung Lee is an accomplished Principal Scientist currently at Regeneron since October 2022, with prior roles at Stablix, Inc. and Forkhead BioTherapeutics Inc., where responsibilities included overseeing in vivo pharmacology studies and leading assay development projects. Prior experience includes work as an Associate Research Scientist at Columbia University Irving Medical Center and a Visiting Scientist at Forkhead Biotherapeutics Inc. Additionally, April held postdoctoral positions at Weill Cornell Medicine and SUNY Downstate Medical Center, contributing significant advancements in RNA isolation methods and conditional knockout models. April's expertise is demonstrated through publications and ongoing research efforts in molecular biology and pharmacology.